CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-28 | AYERS JONATHAN W Director | Sale | −2,599 | $562.48 | $1.5M | 647,416 |
| 2021-05-28 | AYERS JONATHAN W Director | Sale | −1,400 | $563.82 | $789K | 646,016 |
| 2021-05-28 | AYERS JONATHAN W Director | Sale | −1,315 | $564.60 | $742K | 644,701 |
| 2021-05-28 | AYERS JONATHAN W Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −9,460 | 115,540 | ||
| 2021-05-25 | AYERS JONATHAN W Director | Exercise or conversion | +5,000 | $79.54 | $398K | 658,701 |
| 2021-05-25 | AYERS JONATHAN W Director | Sale | −4,800 | $552.12 | $2.7M | 653,901 |
| 2021-05-25 | AYERS JONATHAN W Director | Sale | −200 | $553.37 | $111K | 653,701 |
| 2021-05-25 | AYERS JONATHAN W Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −5,000 | 125,000 | ||
| 2021-05-24 | Turner Kathy V Senior Vice President | Sale | −900 | $549.00 | $494K | 6,866 |
| 2021-05-24 | Turner Kathy V Senior Vice President | Sale | −2,000 | $545.00 | $1.1M | 4,866 |
| 2021-05-24 | AYERS JONATHAN W Director | Exercise or conversion | +5,000 | $79.54 | $398K | 658,701 |
| 2021-05-24 | AYERS JONATHAN W Director | Sale | −5,000 | $546.98 | $2.7M | 653,701 |
| 2021-05-24 | AYERS JONATHAN W Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −5,000 | 130,000 | ||
| 2021-05-21 | JUNIUS DANIEL M Director | Exercise or conversion | +2,500 | $85.00 | $213K | 5,386 |
| 2021-05-21 | JUNIUS DANIEL M Director | Sale | −2,500 | $539.57 | $1.3M | 2,886 |
| 2021-05-21 | JUNIUS DANIEL M Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −2,500 | 2,402 | ||
| 2021-05-21 | Turner Kathy V Senior Vice President | Sale | −1,000 | $545.00 | $545K | 7,766 |
| 2021-05-20 | Turner Kathy V Senior Vice President | Sale | −1,000 | $535.00 | $535K | 9,766 |
| 2021-05-20 | Turner Kathy V Senior Vice President | Sale | −1,000 | $540.00 | $540K | 8,766 |
| 2021-05-20 | AYERS JONATHAN W Director | Exercise or conversion | +5,000 | $79.54 | $398K | 658,701 |
Page 70 of 74 · 1,474 trades